ATLANTIC AMERICAN CORP - Quarter Report: 2017 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☑ |
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended September 30, 2017
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number 0-3722
ATLANTIC AMERICAN CORPORATION
(Exact name of registrant as specified in its charter)
Georgia
|
58-1027114
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
4370 Peachtree Road, N.E.,
Atlanta, Georgia
|
30319
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(404) 266-5500
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company ☑ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
The total number of shares of the registrant’s Common Stock, $1 par value, outstanding on November 7, 2017 was 20,439,411.
ATLANTIC AMERICAN CORPORATION
Part I. Financial Information
|
Page No.
|
|
Item 1.
|
Financial Statements:
|
|
2
|
||
3
|
||
4
|
||
5
|
||
6
|
||
7
|
||
Item 2.
|
21
|
|
Item 4.
|
29
|
|
Part II. Other Information
|
||
Item 2.
|
30
|
|
Item 6.
|
30
|
|
Signatures |
31
|
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
ATLANTIC AMERICAN CORPORATION
(Dollars in thousands, except per share data)
ASSETS
Unaudited
September 30, |
December 31,
2016 |
|||||||
Cash and cash equivalents
|
$
|
9,473
|
$
|
13,252
|
||||
Investments:
|
||||||||
Fixed maturities (cost: $215,241 and $210,505)
|
217,999
|
210,670
|
||||||
Common and non-redeemable preferred stocks (cost: $10,918 and $11,453)
|
21,582
|
20,257
|
||||||
Other invested assets (cost: $9,167 and $9,709)
|
9,167
|
9,709
|
||||||
Policy loans
|
2,113
|
2,265
|
||||||
Real estate
|
38
|
38
|
||||||
Investment in unconsolidated trusts
|
1,238
|
1,238
|
||||||
Total investments
|
252,137
|
244,177
|
||||||
Receivables:
|
||||||||
Reinsurance
|
16,871
|
11,703
|
||||||
Insurance premiums and other (net of allowance for doubtful accounts: $219 and $280)
|
15,572
|
12,581
|
||||||
Deferred income taxes, net
|
-
|
160
|
||||||
Deferred acquisition costs
|
32,159
|
28,975
|
||||||
Other assets
|
5,549
|
5,208
|
||||||
Intangibles
|
2,544
|
2,544
|
||||||
Total assets
|
$
|
334,305
|
$
|
318,600
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
Insurance reserves and policyholder funds:
|
||||||||
Future policy benefits
|
$
|
80,015
|
$
|
74,843
|
||||
Unearned premiums
|
26,501
|
23,208
|
||||||
Losses and claims
|
67,184
|
62,562
|
||||||
Other policy liabilities
|
1,492
|
2,066
|
||||||
Total insurance reserves and policyholder funds
|
175,192
|
162,679
|
||||||
Accounts payable and accrued expenses
|
14,880
|
16,677
|
||||||
Deferred income taxes, net
|
975
|
-
|
||||||
Junior subordinated debenture obligations, net
|
33,738
|
33,738
|
||||||
Total liabilities
|
224,785
|
213,094
|
||||||
Commitments and contingencies (Note 9)
|
||||||||
Shareholders’ equity:
|
||||||||
Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value
|
55
|
55
|
||||||
Common stock, $1 par, 50,000,000 shares authorized; shares issued: 22,400,894; shares outstanding: 20,453,217 and 20,446,705
|
22,401
|
22,401
|
||||||
Additional paid-in capital
|
57,420
|
57,114
|
||||||
Retained earnings
|
28,551
|
27,272
|
||||||
Accumulated other comprehensive income
|
8,725
|
5,830
|
||||||
Unearned stock grant compensation
|
(587
|
)
|
(428
|
)
|
||||
Treasury stock, at cost: 1,947,677 and 1,954,189 shares
|
(7,045
|
)
|
(6,738
|
)
|
||||
Total shareholders’ equity
|
109,520
|
105,506
|
||||||
Total liabilities and shareholders’ equity
|
$
|
334,305
|
$
|
318,600
|
The accompanying notes are an integral part of these consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands, except per share data)
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
Revenue:
|
||||||||||||||||
Insurance premiums
|
$
|
42,094
|
$
|
39,432
|
$
|
122,996
|
$
|
117,012
|
||||||||
Investment income
|
2,136
|
2,453
|
6,380
|
7,523
|
||||||||||||
Realized investment gains, net
|
539
|
527
|
2,818
|
1,411
|
||||||||||||
Other income
|
29
|
35
|
95
|
102
|
||||||||||||
Total revenue
|
44,798
|
42,447
|
132,289
|
126,048
|
||||||||||||
Benefits and expenses:
|
||||||||||||||||
Insurance benefits and losses incurred
|
30,417
|
26,955
|
87,446
|
78,702
|
||||||||||||
Commissions and underwriting expenses
|
10,176
|
11,558
|
31,800
|
34,339
|
||||||||||||
Interest expense
|
440
|
396
|
1,273
|
1,154
|
||||||||||||
Other expense
|
3,134
|
3,221
|
9,301
|
9,803
|
||||||||||||
Total benefits and expenses
|
44,167
|
42,130
|
129,820
|
123,998
|
||||||||||||
Income before income taxes
|
631
|
317
|
2,469
|
2,050
|
||||||||||||
Income tax expense (benefit)
|
(116
|
)
|
168
|
483
|
762
|
|||||||||||
Net income
|
747
|
149
|
1,986
|
1,288
|
||||||||||||
Preferred stock dividends
|
(100
|
)
|
(100
|
)
|
(299
|
)
|
(299
|
)
|
||||||||
Net income applicable to common shareholders
|
$
|
647
|
$
|
49
|
$
|
1,687
|
$
|
989
|
||||||||
Earnings per common share (basic and diluted)
|
$
|
.03
|
$
|
-
|
$
|
.08
|
$
|
.05
|
The accompanying notes are an integral part of these consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands)
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
Net income
|
$
|
747
|
$
|
149
|
$
|
1,986
|
$
|
1,288
|
||||||||
Other comprehensive income:
|
||||||||||||||||
Available-for-sale securities:
|
||||||||||||||||
Gross unrealized holding gain arising in the period
|
2,852
|
1,842
|
7,271
|
10,554
|
||||||||||||
Related income tax effect
|
(997
|
)
|
(645
|
)
|
(2,544
|
)
|
(3,694
|
)
|
||||||||
Less: reclassification adjustment for net realized gains included in net income (1)
|
(539
|
)
|
(527
|
)
|
(2,818
|
)
|
(1,411
|
)
|
||||||||
Related income tax effect (2)
|
188
|
185
|
986
|
494
|
||||||||||||
Total other comprehensive income, net of tax
|
1,504
|
855
|
2,895
|
5,943
|
||||||||||||
Total comprehensive income
|
$
|
2,251
|
$
|
1,004
|
$
|
4,881
|
$
|
7,231
|
The accompanying notes are an integral part of these consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands)
Nine Months Ended September 30, 2017
|
Preferred
Stock
|
Common
Stock
|
Additional
Paid-In
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income
|
Unearned
Stock Grant
Compensation
|
Treasury
Stock
|
Total
|
||||||||||||||||||||||||
Balance, December 31, 2016
|
$
|
55
|
$
|
22,401
|
$
|
57,114
|
$
|
27,272
|
$
|
5,830
|
$
|
(428
|
)
|
$
|
(6,738
|
)
|
$
|
105,506
|
||||||||||||||
Net income
|
-
|
-
|
-
|
1,986
|
-
|
-
|
-
|
1,986
|
||||||||||||||||||||||||
Other comprehensive income, net of tax
|
-
|
-
|
-
|
-
|
2,895
|
-
|
-
|
2,895
|
||||||||||||||||||||||||
Dividends on common stock
|
-
|
-
|
-
|
(408
|
)
|
-
|
-
|
-
|
(408
|
)
|
||||||||||||||||||||||
Dividends accrued on preferred stock
|
-
|
-
|
-
|
(299
|
)
|
-
|
-
|
-
|
(299
|
)
|
||||||||||||||||||||||
Restricted stock grants
|
-
|
-
|
293
|
-
|
-
|
(522
|
)
|
229
|
-
|
|||||||||||||||||||||||
Amortization of unearned compensation
|
-
|
-
|
-
|
-
|
-
|
363
|
-
|
363
|
||||||||||||||||||||||||
Purchase of shares for treasury
|
-
|
-
|
-
|
-
|
-
|
-
|
(546
|
)
|
(546
|
)
|
||||||||||||||||||||||
Issuance of shares under stock plans
|
-
|
-
|
13
|
-
|
-
|
-
|
10
|
23
|
||||||||||||||||||||||||
Balance, September 30, 2017
|
$
|
55
|
$
|
22,401
|
$
|
57,420
|
$
|
28,551
|
$
|
8,725
|
$
|
(587
|
)
|
$
|
(7,045
|
)
|
$
|
109,520
|
||||||||||||||
Nine Months Ended September 30, 2016
|
||||||||||||||||||||||||||||||||
Balance, December 31, 2015
|
$
|
55
|
$
|
22,401
|
$
|
56,623
|
$
|
25,443
|
$
|
4,584
|
$
|
(273
|
)
|
$
|
(6,341
|
)
|
$
|
102,492
|
||||||||||||||
Net income
|
-
|
-
|
-
|
1,288
|
-
|
-
|
-
|
1,288
|
||||||||||||||||||||||||
Other comprehensive income, net of tax
|
-
|
-
|
-
|
-
|
5,943
|
-
|
-
|
5,943
|
||||||||||||||||||||||||
Dividends on common stock
|
-
|
-
|
-
|
(408
|
)
|
-
|
-
|
-
|
(408
|
)
|
||||||||||||||||||||||
Dividends accrued on preferred stock
|
-
|
-
|
-
|
(299
|
)
|
-
|
-
|
-
|
(299
|
)
|
||||||||||||||||||||||
Restricted stock grants
|
-
|
-
|
346
|
-
|
-
|
(556
|
)
|
210
|
-
|
|||||||||||||||||||||||
Amortization of unearned compensation
|
-
|
-
|
-
|
-
|
-
|
457
|
-
|
457
|
||||||||||||||||||||||||
Purchase of shares for treasury
|
-
|
-
|
-
|
-
|
-
|
-
|
(565
|
)
|
(565
|
)
|
||||||||||||||||||||||
Issuance of shares under stock plans
|
-
|
-
|
26
|
-
|
-
|
-
|
17
|
43
|
||||||||||||||||||||||||
Balance, September 30, 2016
|
$
|
55
|
$
|
22,401
|
$
|
56,995
|
$
|
26,024
|
$
|
10,527
|
$
|
(372
|
)
|
$
|
(6,679
|
)
|
$
|
108,951
|
The accompanying notes are an integral part of these consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands)
Nine Months Ended
September 30,
|
||||||||
2017
|
2016
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net income
|
$
|
1,986
|
$
|
1,288
|
||||
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
Amortization of deferred acquisition costs
|
8,696
|
6,764
|
||||||
Acquisition costs deferred
|
(11,880
|
)
|
(7,689
|
)
|
||||
Realized investment gains, net
|
(2,818
|
)
|
(1,411
|
)
|
||||
Compensation expense related to share awards
|
363
|
457
|
||||||
Depreciation and amortization
|
1,149
|
860
|
||||||
Deferred income tax (benefit) expense
|
(423
|
)
|
161
|
|||||
Increase in receivables, net
|
(8,289
|
)
|
(65
|
)
|
||||
Increase (decrease) in insurance reserves
|
12,513
|
(1,745
|
)
|
|||||
Decrease in other liabilities
|
(2,096
|
)
|
(644
|
)
|
||||
Other, net
|
(344
|
)
|
(252
|
)
|
||||
Net cash used in operating activities
|
(1,143
|
)
|
(2,276
|
)
|
||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Proceeds from investments sold
|
52,760
|
48,729
|
||||||
Proceeds from investments matured, called or redeemed
|
8,982
|
9,247
|
||||||
Investments purchased
|
(63,346
|
)
|
(58,193
|
)
|
||||
Additions to property and equipment
|
(101
|
)
|
(335
|
)
|
||||
Net cash used in investing activities
|
(1,705
|
)
|
(552
|
)
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Payment of dividends on common stock
|
(408
|
)
|
(408
|
)
|
||||
Proceeds from shares issued under stock plans
|
23
|
43
|
||||||
Purchase of shares for treasury
|
(546
|
)
|
(565
|
)
|
||||
Net cash used in financing activities
|
(931
|
)
|
(930
|
)
|
||||
Net decrease in cash and cash equivalents
|
(3,779
|
)
|
(3,758
|
)
|
||||
Cash and cash equivalents at beginning of period
|
13,252
|
15,622
|
||||||
Cash and cash equivalents at end of period
|
$
|
9,473
|
$
|
11,864
|
||||
SUPPLEMENTAL CASH FLOW INFORMATION:
|
||||||||
Cash paid for interest
|
$
|
1,263
|
$
|
1,142
|
||||
Cash paid for income taxes
|
$
|
1,400
|
$
|
675
|
The accompanying notes are an integral part of these consolidated financial statements.
ATLANTIC AMERICAN CORPORATION
(Unaudited; Dollars in thousands, except per share amounts)
Note 1. |
Basis of Presentation
|
The accompanying unaudited condensed consolidated financial statements include the accounts of Atlantic American Corporation (the “Parent”) and its subsidiaries (collectively with the Parent, the “Company”). The Parent’s primary operating subsidiaries, American Southern Insurance Company and American Safety Insurance Company (together known as “American Southern”) and Bankers Fidelity Life Insurance Company and Bankers Fidelity Assurance Company (together known as “Bankers Fidelity”) operate in two principal business units. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for audited annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The unaudited condensed consolidated financial statements included herein and these related notes should be read in conjunction with the Company’s consolidated financial statements, and the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 (the “Annual Report”). The Company’s financial condition and results of operations and cash flows as of and for the three month and nine month periods ended September 30, 2017 are not necessarily indicative of the financial condition or results of operations and cash flows that may be expected for the year ending December 31, 2017 or for any other future period.
The Company’s significant accounting policies have not changed materially from those set out in the Annual Report.
The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.
Note 2. |
Recently Issued Accounting Standards
|
Adoption of New Accounting Standards
In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). This guidance applies to all entities that issue share-based payment awards to their employees and is designed to simplify several areas of the accounting for share-based payment transactions, including income tax consequences, forfeitures, classification of awards as either equity or liabilities and related classification on the statement of cash flows. The guidance requires the excess tax benefit or deficiency on vesting or settlement of awards to be recognized in earnings as an income tax benefit or expense, respectively. The Company adopted ASU 2016-09 as of January 1, 2017. Adoption of ASU 2016-09 did not have a material impact on the Company’s consolidated financial statements.
In March 2016, the FASB issued ASU No. 2016-07, Investments – Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting (“ASU 2016-07”). This guidance eliminates the requirement to retroactively adopt the equity method of accounting when an investment qualifies for the use of the equity method as a result of an increase in the level of ownership or degree of influence. Under ASU 2016-07, the equity method investor is required to add the cost of acquiring the additional interest in the investee to the current basis of the previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. The Company adopted ASU 2016-07 as of January 1, 2017. Adoption of ASU 2016-07 did not have an impact on the Company’s consolidated financial statements.
Future Adoption of New Accounting Standards
In March 2017, the FASB issued ASU No. 2017-08, Receivables – Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities (“ASU 2017-08”). This guidance shortens the amortization period for certain callable debt securities held at a premium to the earliest call date. Under current GAAP, premiums and discounts on callable securities generally are amortized to the maturity date. ASU 2017-08 is effective for interim and annual reporting periods beginning after December 15, 2018, although earlier adoption is permitted. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) ( "ASU 2014-09"). ASU 2014-09 as modified provides guidance for recognizing revenue. The guidance excludes insurance contracts and financial instruments. Revenue is to be recognized when, or as, goods or services are transferred to customers in an amount that reflects the consideration that an entity is expected to be entitled in exchange for those goods or services. This guidance is effective retrospectively on January 1, 2018, with a choice of restating prior periods or recognizing a cumulative effect for contracts in place as of adoption. Early adoption is permitted as of January 1, 2017. The Company will adopt this ASU on January 1, 2018. Based on current evaluations, the adoption is not expected to have a material impact on the Company's consolidated financial statements.
Note 3. |
Investments
|
The following tables set forth the carrying value, gross unrealized gains, gross unrealized losses and cost or amortized cost of the Company’s investments, aggregated by type and industry, as of September 30, 2017 and December 31, 2016.
September 30, 2017
|
||||||||||||||||
Carrying
Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
Fixed maturities:
|
||||||||||||||||
Bonds:
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
32,426
|
$
|
189
|
$
|
414
|
$
|
32,651
|
||||||||
Obligations of states and political subdivisions
|
17,882
|
696
|
54
|
17,240
|
||||||||||||
Corporate securities:
|
||||||||||||||||
Utilities and telecom
|
20,463
|
1,636
|
76
|
18,903
|
||||||||||||
Financial services
|
51,927
|
2,161
|
411
|
50,177
|
||||||||||||
Other business – diversified
|
41,339
|
941
|
1,499
|
41,897
|
||||||||||||
Other consumer – diversified
|
53,770
|
910
|
1,321
|
54,181
|
||||||||||||
Total corporate securities
|
167,499
|
5,648
|
3,307
|
165,158
|
||||||||||||
Redeemable preferred stocks:
|
||||||||||||||||
Other consumer – diversified
|
192
|
-
|
-
|
192
|
||||||||||||
Total redeemable preferred stocks
|
192
|
-
|
-
|
192
|
||||||||||||
Total fixed maturities
|
217,999
|
6,533
|
3,775
|
215,241
|
||||||||||||
Equity securities:
|
||||||||||||||||
Common and non-redeemable preferred stocks:
|
||||||||||||||||
Utilities and telecom
|
1,484
|
520
|
-
|
964
|
||||||||||||
Financial services
|
5,579
|
796
|
-
|
4,783
|
||||||||||||
Other business – diversified
|
275
|
228
|
-
|
47
|
||||||||||||
Other consumer – diversified
|
14,244
|
9,120
|
-
|
5,124
|
||||||||||||
Total equity securities
|
21,582
|
10,664
|
-
|
10,918
|
||||||||||||
Other invested assets
|
9,167
|
-
|
-
|
9,167
|
||||||||||||
Policy loans
|
2,113
|
-
|
-
|
2,113
|
||||||||||||
Real estate
|
38
|
-
|
-
|
38
|
||||||||||||
Investments in unconsolidated trusts
|
1,238
|
-
|
-
|
1,238
|
||||||||||||
Total investments
|
$
|
252,137
|
$
|
17,197
|
$
|
3,775
|
$
|
238,715
|
December 31, 2016
|
||||||||||||||||
Carrying
Value
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Cost or
Amortized
Cost
|
|||||||||||||
Fixed maturities:
|
||||||||||||||||
Bonds:
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
31,102
|
$
|
197
|
$
|
553
|
$
|
31,458
|
||||||||
Obligations of states and political subdivisions
|
17,572
|
625
|
308
|
17,255
|
||||||||||||
Corporate securities:
|
||||||||||||||||
Utilities and telecom
|
18,034
|
1,462
|
88
|
16,660
|
||||||||||||
Financial services
|
57,282
|
1,880
|
911
|
56,313
|
||||||||||||
Other business – diversified
|
57,419
|
1,071
|
2,337
|
58,685
|
||||||||||||
Other consumer – diversified
|
29,069
|
471
|
1,344
|
29,942
|
||||||||||||
Total corporate securities
|
161,804
|
4,884
|
4,680
|
161,600
|
||||||||||||
Redeemable preferred stocks:
|
||||||||||||||||
Other consumer – diversified
|
192
|
-
|
-
|
192
|
||||||||||||
Total redeemable preferred stocks
|
192
|
-
|
-
|
192
|
||||||||||||
Total fixed maturities
|
210,670
|
5,706
|
5,541
|
210,505
|
||||||||||||
Equity securities: | ||||||||||||||||
Common and non-redeemable preferred stocks:
|
||||||||||||||||
Utilities and telecom
|
1,601
|
637
|
-
|
964
|
||||||||||||
Financial services
|
5,402
|
574
|
-
|
4,828
|
||||||||||||
Other business – diversified
|
244
|
197
|
-
|
47
|
||||||||||||
Other consumer – diversified
|
13,010
|
7,396
|
-
|
5,614
|
||||||||||||
Total equity securities
|
20,257
|
8,804
|
-
|
11,453
|
||||||||||||
Other invested assets
|
9,709
|
-
|
-
|
9,709
|
||||||||||||
Policy loans
|
2,265
|
-
|
-
|
2,265
|
||||||||||||
Real estate
|
38
|
-
|
-
|
38
|
||||||||||||
Investments in unconsolidated trusts
|
1,238
|
-
|
-
|
1,238
|
||||||||||||
Total investments
|
$
|
244,177
|
$
|
14,510
|
$
|
5,541
|
$
|
235,208
|
Bonds having an amortized cost of $11,219 and $11,435 and included in the tables above were on deposit with insurance regulatory authorities at September 30, 2017 and December 31, 2016, respectively, in accordance with statutory requirements.
The carrying value and amortized cost of the Company’s investments in fixed maturities at September 30, 2017 and December 31, 2016 by contractual maturity were as follows. Actual maturities may differ from contractual maturities because issuers may call or prepay obligations with or without call or prepayment penalties.
September 30, 2017
|
December 31, 2016
|
|||||||||||||||
Carrying
Value
|
Amortized
Cost
|
Carrying
Value
|
Amortized
Cost
|
|||||||||||||
Due in one year or less
|
$
|
1,415
|
$
|
1,411
|
$
|
2,544
|
$
|
2,507
|
||||||||
Due after one year through five years
|
16,612
|
16,795
|
20,278
|
20,038
|
||||||||||||
Due after five years through ten years
|
104,519
|
103,571
|
90,667
|
90,926
|
||||||||||||
Due after ten years
|
75,117
|
72,923
|
80,099
|
79,627
|
||||||||||||
Varying maturities
|
20,336
|
20,541
|
17,082
|
17,407
|
||||||||||||
Totals
|
$
|
217,999
|
$
|
215,241
|
$
|
210,670
|
$
|
210,505
|
The following table sets forth the carrying value, cost or amortized cost, and net unrealized gains (losses) of the Company’s investments aggregated by industry as of September 30, 2017 and December 31, 2016.
September 30, 2017
|
December 31, 2016
|
|||||||||||||||||||||||
Carrying
Value
|
Cost or
Amortized
Cost
|
Unrealized
Gains
(Losses)
|
Carrying
Value
|
Cost or
Amortized
Cost
|
Unrealized
Gains
(Losses)
|
|||||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
32,426
|
$
|
32,651
|
$
|
(225
|
)
|
$
|
31,102
|
$
|
31,458
|
$
|
(356
|
)
|
||||||||||
Obligations of states and political subdivisions
|
17,882
|
17,240
|
642
|
17,572
|
17,255
|
317
|
||||||||||||||||||
Utilities and telecom
|
21,947
|
19,867
|
2,080
|
19,635
|
17,624
|
2,011
|
||||||||||||||||||
Financial services
|
57,506
|
54,960
|
2,546
|
62,684
|
61,141
|
1,543
|
||||||||||||||||||
Other business – diversified
|
41,614
|
41,944
|
(330
|
)
|
57,663
|
58,732
|
(1,069
|
)
|
||||||||||||||||
Other consumer – diversified
|
68,206
|
59,497
|
8,709
|
42,271
|
35,748
|
6,523
|
||||||||||||||||||
Other investments
|
12,556
|
12,556
|
-
|
13,250
|
13,250
|
-
|
||||||||||||||||||
Investments
|
$
|
252,137
|
$
|
238,715
|
$
|
13,422
|
$
|
244,177
|
$
|
235,208
|
$
|
8,969
|
The following tables present the Company’s unrealized loss aging for securities by type and length of time the security was in a continuous unrealized loss position as of September 30, 2017 and December 31, 2016.
September 30, 2017
|
||||||||||||||||||||||||
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
15,900
|
$
|
188
|
$
|
9,016
|
$
|
226
|
$
|
24,916
|
$
|
414
|
||||||||||||
Obligations of states and political subdivisions
|
2,994
|
17
|
1,978
|
37
|
4,972
|
54
|
||||||||||||||||||
Corporate securities
|
30,340
|
451
|
33,204
|
2,856
|
63,544
|
3,307
|
||||||||||||||||||
Total temporarily impaired securities
|
$
|
49,234
|
$
|
656
|
$
|
44,198
|
$
|
3,119
|
$
|
93,432
|
$
|
3,775
|
December 31, 2016
|
||||||||||||||||||||||||
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
Fair
Value
|
Unrealized
Losses
|
|||||||||||||||||||
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
|
$
|
23,494
|
$
|
553
|
$
|
-
|
$
|
-
|
$
|
23,494
|
$
|
553
|
||||||||||||
Obligations of states and political subdivisions
|
8,747
|
308
|
-
|
-
|
8,747
|
308
|
||||||||||||||||||
Corporate securities
|
59,404
|
2,124
|
20,587
|
2,556
|
79,991
|
4,680
|
||||||||||||||||||
Total temporarily impaired securities
|
$
|
91,645
|
$
|
2,985
|
$
|
20,587
|
$
|
2,556
|
$
|
112,232
|
$
|
5,541
|
The evaluation for an other than temporary impairment is a quantitative and qualitative process, which is subject to risks and uncertainties in the determination of whether declines in the fair value of investments are other than temporary. Potential risks and uncertainties include, among other things, changes in general economic conditions, an issuer’s financial condition or near term recovery prospects and the effects of changes in interest rates. In evaluating a potential impairment, the Company considers, among other factors, management’s intent and ability to hold the securities until price recovery, the nature of the investment and the expectation of prospects for the issuer and its industry, the status of an issuer’s continued satisfaction of its obligations in accordance with their contractual terms, and management’s expectation as to the issuer’s ability and intent to continue to do so, as well as ratings actions that may affect the issuer’s credit status.
As of September 30, 2017, there were sixty-three securities in an unrealized loss position which primarily included certain of the Company’s investments in fixed maturities within the other diversified business and other diversified consumer sectors. Securities in an unrealized loss position reported in the other diversified business sector included gross unrealized losses of $1,006 related to investments in fixed maturities of five different issuers, all related to the oil and gas industry. The oil and gas companies represent a diversified group of businesses which include, among others, exploration and production, pipeline owners and operators, deep water offshore rig owners and operators, all of which we believe are in continuing stages of rationalizing their current operations, investments, future capital expenditures and carefully managing and modifying their capital and liquidity positions. Based on publicly available information, the companies are continuing to assess and revise short-term, intermediate and long-term business plans in response to the current trends in oil and gas markets. While these companies have generally experienced credit downgrades or may be currently under credit rating review, the Company believes that many of the downgrades are in response to external market forces and not necessarily specific credit events of any obligor which would currently indicate that an other than temporary impairment need be recorded. All of the investees have continued to make regular interest payments on their debt when and as due and the Company continues to perform in-depth analyses of the publicly available financial disclosures of each of the investees on a regular basis. The Company does not currently intend to sell nor does it expect to be required to sell any of the securities in an unrealized loss position. Based upon the Company’s expected continuation of receipt of contractually required principal and interest payments and its intent and ability to retain the securities until price recovery, as well as the Company’s evaluation of other relevant factors, including those described above, the Company has deemed these securities to be temporarily impaired as of September 30, 2017.
The following describes the fair value hierarchy and provides information as to the extent to which the Company uses fair value to measure the value of its financial instruments and information about the inputs used to value those financial instruments. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad levels.
Level 1 |
Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company’s financial instruments valued using Level 1 criteria include cash equivalents and exchange traded common stocks.
|
Level 2 |
Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company’s financial instruments valued using Level 2 criteria include significantly all of its fixed maturities, which consist of U.S. Treasury securities and U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In determining fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers. Prices for the majority of the Company’s Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize a matrix pricing concept, which is a mathematical technique used widely in the industry to value debt securities based on various relationships to other benchmark quoted prices.
|
Level 3 |
Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily observable from objective sources. The Company’s financial instruments valued using Level 3 criteria consist of a limited number of fixed maturities. As of September 30, 2017 and December 31, 2016, the value of the Company’s fixed maturities valued using Level 3 criteria was $1,351 and $1,264, respectively. The use of different criteria or assumptions regarding data may have yielded materially different valuations.
|
As of September 30, 2017, financial instruments carried at fair value were measured on a recurring basis as summarized below:
Quoted Prices
in Active
Markets
for Identical
Assets
|
Significant
Other
Observable
Inputs
|
Significant
Unobservable
Inputs
|
||||||||||||||
(Level 1)
|
(Level 2)
|
(Level 3)
|
Total
|
|||||||||||||
Assets:
|
||||||||||||||||
Fixed maturities
|
$
|
-
|
$
|
216,648
|
$
|
1,351
|
(1)
|
$
|
217,999
|
|||||||
Equity securities
|
16,233
|
5,349
|
(1)
|
-
|
21,582
|
|||||||||||
Cash equivalents
|
8,884
|
-
|
|
-
|
8,884
|
|||||||||||
Total
|
$
|
25,117
|
$
|
221,997
|
$
|
1,351
|
$
|
248,465
|
(1) |
All underlying securities are financial service industry related.
|
As of December 31, 2016, financial instruments carried at fair value were measured on a recurring basis as summarized below:
Quoted Prices
in Active
Markets
for Identical
Assets
|
Significant
Other
Observable
Inputs
|
Significant
Unobservable
Inputs
|
||||||||||||||
(Level 1)
|
(Level 2)
|
(Level 3)
|
Total
|
|||||||||||||
Assets:
|
||||||||||||||||
Fixed maturities
|
$
|
-
|
$
|
209,406
|
$
|
1,264
|
(1)
|
$
|
210,670
|
|||||||
Equity securities
|
15,153
|
5,104
|
(1)
|
-
|
20,257
|
|||||||||||
Cash equivalents
|
9,811
|
-
|
-
|
9,811
|
||||||||||||
Total
|
$
|
24,964
|
$
|
214,510
|
$
|
1,264
|
$
|
240,738
|
(1) |
All underlying securities are financial service industry related.
|
The following tables provide a roll-forward of the Company’s financial instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three month and nine month periods ended September 30, 2017 and 2016.
Fixed
Maturities
|
||||
Balance, December 31, 2016
|
$
|
1,264
|
||
Total unrealized gains included in other comprehensive income
|
38
|
|||
Balance, March 31, 2017
|
1,302
|
|||
Total unrealized gains included in other comprehensive income
|
30
|
|||
Balance, June 30, 2017
|
1,332
|
|||
Total unrealized gains included in other comprehensive income
|
19
|
|||
Balance, September 30, 2017
|
$
|
1,351
|
Fixed
Maturities
|
||||
Balance, December 31, 2015
|
$
|
2,237
|
||
Total unrealized gains included in other comprehensive income
|
63
|
|||
Balance, March 31, 2016
|
2,300
|
|||
Total unrealized gains included in other comprehensive income
|
68
|
|||
Balance, June 30, 2016
|
2,368
|
|||
Total realized gains included in earnings
|
57
|
|||
Total unrealized losses included in other comprehensive income
|
(61
|
)
|
||
Settlements
|
(1,000
|
)
|
||
Balance, September 30, 2016
|
$
|
1,364
|
The Company’s fixed maturities valued using Level 3 inputs consist solely of issuances of pooled debt obligations of multiple, smaller financial services companies. They are not actively traded and valuation techniques used to measure fair value are based on future estimated cash flows (based on current cash flows) discounted at reasonable estimated rates of interest. There are no assumed prepayments and/or default probability assumptions as a majority of these instruments contain certain U.S. government agency strips to support repayment of the principal. Other qualitative and quantitative information received from the original underwriter of the pooled offerings is also considered, as applicable.
The following table is a summary of realized investment gains (losses) for the three month and nine month periods ended September 30, 2017 and 2016.
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
Gross gains
|
$
|
539
|
$
|
543
|
$
|
2,879
|
$
|
1,497
|
||||||||
Gross losses
|
-
|
(16
|
)
|
(61
|
)
|
(86
|
)
|
|||||||||
Realized investment gains, net
|
$
|
539
|
$
|
527
|
$
|
2,818
|
$
|
1,411
|
Note 4.
|
Fair Values of Financial Instruments
|
The estimated fair values have been determined by the Company using available market information from various market sources and appropriate valuation methodologies as of the respective dates. However, considerable judgment is necessary to interpret market data and to develop the estimates of fair value. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, the estimates presented herein are not necessarily indicative of the amounts which the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.
The following table sets forth the carrying amount, estimated fair value and level within the fair value hierarchy of the Company’s financial instruments as of September 30, 2017 and December 31, 2016.
September 30, 2017
|
December 31, 2016
|
|||||||||||||||||||
Level in Fair
Value
Hierarchy (1)
|
Carrying
Amount
|
Estimated
Fair Value
|
Carrying
Amount
|
Estimated
Fair Value
|
||||||||||||||||
Assets:
|
||||||||||||||||||||
Cash and cash equivalents
|
Level 1
|
$
|
9,473
|
$
|
9,473
|
$
|
13,252
|
$
|
13,252
|
|||||||||||
Fixed maturities
|
(1)
|
217,999
|
217,999
|
210,670
|
210,670
|
|||||||||||||||
Equity securities
|
(1)
|
21,582
|
21,582
|
20,257
|
20,257
|
|||||||||||||||
Other invested assets
|
Level 3
|
9,167
|
9,167
|
9,709
|
9,709
|
|||||||||||||||
Policy loans
|
Level 2
|
2,113
|
2,113
|
2,265
|
2,265
|
|||||||||||||||
Real estate
|
Level 2
|
38
|
38
|
38
|
38
|
|||||||||||||||
Investment in unconsolidated trusts
|
Level 2
|
1,238
|
1,238
|
1,238
|
1,238
|
|||||||||||||||
Liabilities:
|
||||||||||||||||||||
Junior subordinated debentures, net
|
Level 2
|
33,738
|
33,738
|
33,738
|
33,738
|
(1) |
See Note 3 for a description of the fair value hierarchy as well as a disclosure of levels for classes of these financial assets.
|
There have not been any transfers between Level 1, Level 2 and Level 3 during the periods presented in these condensed consolidated financial statements.
Note 5.
|
Liabilities for Unpaid Losses, Claims and Loss Adjustment Expenses
|
The roll-forward of liabilities for unpaid losses, claims and loss adjustment expenses, by major product, is as follows:
Property and Casualty Insurance Products
|
Nine Months Ended
September 30,
|
|||||||
2017
|
2016
|
|||||||
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
49,556
|
$
|
51,200
|
||||
Less: Reinsurance recoverable on unpaid losses
|
(9,806
|
)
|
(11,639
|
)
|
||||
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, net
|
39,750
|
39,561
|
||||||
Incurred related to:
|
||||||||
Current accident year
|
27,359
|
26,534
|
||||||
Prior accident year development (1)
|
(1,480
|
)
|
(1,296
|
)
|
||||
Total incurred
|
25,879
|
25,238
|
||||||
Paid related to:
|
||||||||
Current accident year
|
9,858
|
9,799
|
||||||
Prior accident years
|
13,720
|
15,950
|
||||||
Total paid
|
23,578
|
25,749
|
||||||
Ending liabilities for unpaid losses, claims and loss adjustment expenses, net
|
42,051
|
39,050
|
||||||
Plus: Reinsurance recoverable on unpaid losses
|
9,455
|
9,234
|
||||||
Ending liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
51,506
|
$
|
48,284
|
(1) |
In establishing property and casualty reserves, the Company initially reserves for losses at the higher end of the reasonable range if no other value within the range is determined to be more probable. Selection of such an initial loss estimate is an attempt by management to give recognition that initial claims information received generally is not conclusive with respect to legal liability, is generally not comprehensive with respect to magnitude of loss and generally, based on historical experience, will develop more adversely as time passes and more information becomes available. However, as a result, the Company generally experiences reserve redundancies when analyzing the development of prior year losses in a current period.
|
Medicare Supplement Insurance Products
|
Nine Months Ended
September 30,
|
|||||||
2017
|
2016
|
|||||||
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
11,263
|
$
|
10,547
|
||||
Less: Reinsurance recoverable on unpaid losses
|
(990
|
)
|
-
|
|||||
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, net
|
10,273
|
10,547
|
||||||
Incurred related to:
|
||||||||
Current accident year
|
50,733
|
46,295
|
||||||
Prior accident year development
|
720
|
(1,009
|
)
|
|||||
Total incurred
|
51,453
|
45,286
|
||||||
Paid related to:
|
||||||||
Current accident year
|
40,801
|
35,986
|
||||||
Prior accident years
|
10,445
|
9,267
|
||||||
Total paid
|
51,246
|
45,253
|
||||||
Ending liabilities for unpaid losses, claims and loss adjustment expenses, net
|
10,480
|
10,580
|
||||||
Plus: Reinsurance recoverable on unpaid losses
|
3,640
|
-
|
||||||
Ending liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
14,120
|
$
|
10,580
|
Other Life and Health Insurance Products
|
Nine Months Ended
September 30,
|
|||||||
2017
|
2016
|
|||||||
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
1,743
|
$
|
2,123
|
||||
Less: Reinsurance recoverable on unpaid losses
|
-
|
-
|
||||||
Beginning liabilities for unpaid losses, claims and loss adjustment expenses, net
|
1,743
|
2,123
|
||||||
Incurred related to:
|
||||||||
Current accident year
|
6,226
|
5,489
|
||||||
Prior accident year development
|
(104
|
)
|
(173
|
)
|
||||
Total incurred
|
6,122
|
5,316
|
||||||
Paid related to:
|
||||||||
Current accident year
|
4,807
|
4,206
|
||||||
Prior accident years
|
1,500
|
1,494
|
||||||
Total paid
|
6,307
|
5,700
|
||||||
Ending liabilities for unpaid losses, claims and loss adjustment expenses, net
|
1,558
|
1,739
|
||||||
Plus: Reinsurance recoverable on unpaid losses
|
-
|
-
|
||||||
Ending liabilities for unpaid losses, claims and loss adjustment expenses, gross
|
$
|
1,558
|
$
|
1,739
|
Following is a reconciliation of total incurred losses to total insurance benefits and losses incurred:
Nine Months Ended
September 30,
|
||||||||
2017
|
2016
|
|||||||
Total incurred losses
|
$
|
83,454
|
$
|
75,840
|
||||
Cash surrender value and matured endowments
|
1,167
|
1,037
|
||||||
Benefit reserve changes
|
2,825
|
1,825
|
||||||
Total insurance benefits and losses incurred
|
$
|
87,446
|
$
|
78,702
|
Note 6.
|
Junior Subordinated Debentures
|
The Company has two unconsolidated Connecticut statutory business trusts, which exist for the exclusive purposes of: (i) issuing trust preferred securities (“Trust Preferred Securities”) representing undivided beneficial interests in the assets of the trusts; (ii) investing the gross proceeds of the Trust Preferred Securities in junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) of Atlantic American; and (iii) engaging in those activities necessary or incidental thereto.
The financial structure of each of Atlantic American Statutory Trust I and II as of September 30, 2017 was as follows:
Atlantic American
Statutory Trust I
|
Atlantic American
Statutory Trust II
|
|||||||
JUNIOR SUBORDINATED DEBENTURES (1) (2)
|
||||||||
Principal amount owed
|
$
|
18,042
|
$
|
23,196
|
||||
Balance September 30, 2017
|
$
|
18,042
|
$
|
23,196
|
||||
Less: Treasury debt (3)
|
-
|
(7,500
|
)
|
|||||
Net balance September 30, 2017
|
$
|
18,042
|
$
|
15,696
|
||||
Net balance December 31, 2016
|
$
|
18,042
|
$
|
15,696
|
||||
Coupon rate
|
LIBOR + 4.00%
|
LIBOR + 4.10%
|
||||||
Interest payable
|
Quarterly
|
Quarterly
|
||||||
Maturity date
|
December 4, 2032
|
May 15, 2033
|
||||||
Redeemable by issuer
|
Yes
|
Yes
|
||||||
TRUST PREFERRED SECURITIES
|
||||||||
Issuance date
|
December 4, 2002
|
May 15, 2003
|
||||||
Securities issued
|
17,500
|
22,500
|
||||||
Liquidation preference per security
|
$
|
1
|
$
|
1
|
||||
Liquidation value
|
$
|
17,500
|
$
|
22,500
|
||||
Coupon rate
|
LIBOR + 4.00%
|
LIBOR + 4.10%
|
||||||
Distribution payable
|
Quarterly
|
Quarterly
|
||||||
Distribution guaranteed by (4)
|
Atlantic American Corporation
|
Atlantic American Corporation
|
(1) |
For each of the respective debentures, the Company has the right at any time, and from time to time, to defer payments of interest on the Junior Subordinated Debentures for a period not exceeding 20 consecutive quarters up to the debentures’ respective maturity dates. During any such period, interest will continue to accrue and the Company may not declare or pay any cash dividends or distributions on, or purchase, the Company’s common stock nor make any principal, interest or premium payments on or repurchase any debt securities that rank equally with or junior to the Junior Subordinated Debentures. The Company has the right at any time to dissolve each of the trusts and cause the Junior Subordinated Debentures to be distributed to the holders of the Trust Preferred Securities.
|
(2) |
The Junior Subordinated Debentures are unsecured and rank junior and subordinate in right of payment to all senior debt of the Parent and are effectively subordinated to all existing and future liabilities of its subsidiaries.
|
(3) |
On August 4, 2014, the Company acquired $7,500 of the Junior Subordinated Debentures.
|
(4) |
The Parent has guaranteed, on a subordinated basis, all of the obligations under the Trust Preferred Securities, including payment of the redemption price and any accumulated and unpaid distributions to the extent of available funds and upon dissolution, winding up or liquidation.
|
Note 7.
|
Earnings Per Common Share
|
A reconciliation of the numerator and denominator used in the earnings per common share calculations is as follows:
Three Months Ended
September 30, 2017
|
|||||||||||
Income
|
Shares
(In thousands)
|
Per Share
Amount
|
|||||||||
Basic and Diluted Earnings Per Common Share:
|
|||||||||||
Net income
|
$
|
747
|
20,440
|
||||||||
Less: preferred stock dividends
|
(100
|
)
|
-
|
||||||||
Net income applicable to common shareholders
|
$
|
647
|
20,440
|
$ |
.03
|
Three Months Ended
September 30, 2016
|
|||||||||||
Income
|
Shares
(In thousands)
|
Per Share
Amount
|
|||||||||
Basic and Diluted Earnings Per Common Share:
|
|||||||||||
Net income
|
$
|
149
|
20,451
|
||||||||
Less: preferred stock dividends
|
(100
|
)
|
-
|
||||||||
Net income applicable to common shareholders
|
$
|
49
|
20,451
|
$ |
-
|
Nine Months Ended
September 30, 2017
|
|||||||||||
Income
|
Shares
(In thousands)
|
Per Share
Amount
|
|||||||||
Basic and Diluted Earnings Per Common Share:
|
|||||||||||
Net income
|
$
|
1,986
|
20,428
|
||||||||
Less: preferred stock dividends
|
(299
|
)
|
-
|
||||||||
Net income applicable to common shareholders
|
$
|
1,687
|
20,428
|
$ |
.08
|
Nine Months Ended
September 30, 2016
|
|||||||||||
Income
|
Shares
(In thousands)
|
Per Share
Amount
|
|||||||||
Basic and Diluted Earnings Per Common Share:
|
|||||||||||
Net income
|
$
|
1,288
|
20,433
|
||||||||
Less: preferred stock dividends
|
(299
|
)
|
-
|
||||||||
Net income applicable to common shareholders
|
$
|
989
|
20,433
|
$ |
.05
|
The assumed conversion of the Company’s Series D preferred stock was excluded from the earnings per common share calculation for all periods presented since its impact would have been antidilutive.
Note 8.
|
Income Taxes
|
A reconciliation of the differences between income taxes computed at the federal statutory income tax rate and income tax expense (benefit) is as follows:
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
Federal income tax provision at statutory rate of 35%
|
$
|
221
|
$
|
110
|
$
|
864
|
$
|
717
|
||||||||
Dividends-received deduction
|
(23
|
)
|
(25
|
)
|
(71
|
)
|
(71
|
)
|
||||||||
Small life insurance company deduction
|
(313
|
)
|
-
|
(343
|
)
|
-
|
||||||||||
Other permanent differences
|
18
|
12
|
52
|
45
|
||||||||||||
Adjustment for prior years’ estimates to actual
|
(19
|
)
|
71
|
(19
|
)
|
71
|
||||||||||
Income tax expense (benefit)
|
$
|
(116
|
)
|
$
|
168
|
$
|
483
|
$
|
762
|
The components of income tax expense (benefit) were:
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
Current - Federal
|
$
|
(157
|
)
|
$
|
11
|
$
|
906
|
$
|
601
|
|||||||
Deferred - Federal
|
41
|
157
|
(423
|
)
|
161
|
|||||||||||
Total
|
$
|
(116
|
)
|
$
|
168
|
$
|
483
|
$
|
762
|
The primary differences between the effective tax rate and the federal statutory income tax rate for the three month and nine month periods ended September 30, 2017 resulted from the dividends-received deduction (“DRD”) and the small life insurance company deduction (“SLD”). The current estimated DRD is adjusted as underlying factors change and can vary from estimates based on, but not limited to, actual distributions from investments as well as the amount of the Company’s taxable income. The SLD varies in amount and is determined at a rate of 60 percent of the tentative life insurance company taxable income (“LICTI”). The SLD for any taxable year is reduced (but not below zero) by 15 percent of the tentative LICTI for such taxable year as it exceeds $3,000 and is ultimately phased out at $15,000.
The primary differences between the effective tax rate and the federal statutory income tax rate for the three month and nine month periods ended September 30, 2016 resulted from provision-to-filed return adjustments, as described below, and the DRD.
The provision-to-filed return adjustments are generally updated at the completion of the third quarter of each fiscal year and were $19 and $71 in the three month and nine month periods ended September 30, 2017 and 2016, respectively.
Note 9.
|
Commitments and Contingencies
|
From time to time, the Company is, and expects to continue to be, involved in various claims and lawsuits incidental to and in the ordinary course of its businesses. In the opinion of management, any such known claims are not expected to have a material effect on the financial condition or results of operations of the Company.
Note 10.
|
Segment Information
|
The Parent’s primary insurance subsidiaries, American Southern and Bankers Fidelity, operate in two principal business units, each focusing on specific products. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each business unit is managed independently and is evaluated on its individual performance. The following sets forth the revenues and income before income taxes for each business unit for the three month and nine month periods ended September 30, 2017 and 2016.
Revenues
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
American Southern
|
$
|
15,047
|
$
|
14,112
|
$
|
43,402
|
$
|
43,743
|
||||||||
Bankers Fidelity
|
29,661
|
28,225
|
87,757
|
81,947
|
||||||||||||
Corporate and Other
|
90
|
110
|
1,130
|
358
|
||||||||||||
Total revenue
|
$
|
44,798
|
$
|
42,447
|
$
|
132,289
|
$
|
126,048
|
Income Before Income Taxes
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
American Southern
|
$
|
1,860
|
$
|
1,855
|
$
|
5,941
|
$
|
5,971
|
||||||||
Bankers Fidelity
|
402
|
164
|
190
|
1,111
|
||||||||||||
Corporate and Other
|
(1,631
|
)
|
(1,702
|
)
|
(3,662
|
)
|
(5,032
|
)
|
||||||||
Income before income taxes
|
$
|
631
|
$
|
317
|
$
|
2,469
|
$
|
2,050
|
Note 11.
|
Accumulated Other Comprehensive Income
|
The following table sets forth the balance of the only component of accumulated other comprehensive income as of September 30, 2017 and December 31, 2016, and the changes in the balance of that component during the nine month period ended September 30, 2017, net of taxes.
Unrealized Gains
on Available-for-
Sale Securities
|
||||
Balance, December 31, 2016
|
$
|
5,830
|
||
Other comprehensive income before reclassifications
|
4,727
|
|||
Amounts reclassified from accumulated other comprehensive income
|
(1,832
|
)
|
||
Net current period other comprehensive income
|
2,895
|
|||
Balance, September 30, 2017
|
$
|
8,725
|
Note 12.
|
Related Party Transactions
|
For the nine month period ended September 30, 2017, Gray Television, Inc., a related party, paid the Company approximately $448 in premiums related to a group accident plan.
Item 2.
AND RESULTS OF OPERATIONS
The following is management’s discussion and analysis of the financial condition and results of operations of Atlantic American Corporation (“Atlantic American” or the “Parent”) and its subsidiaries (collectively with the Parent, the “Company”) as of and for the three month and nine month periods ended September 30, 2017. This discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included elsewhere herein, as well as with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 (the “Annual Report”).
Atlantic American is an insurance holding company whose operations are conducted primarily through its insurance subsidiaries: American Southern Insurance Company and American Safety Insurance Company (together known as “American Southern”) and Bankers Fidelity Life Insurance Company and Bankers Fidelity Assurance Company (together known as “Bankers Fidelity”). Each operating company is managed separately, offers different products and is evaluated on its individual performance.
Critical Accounting Policies
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ significantly from those estimates. The Company has identified certain estimates that involve a higher degree of judgment and are subject to a significant degree of variability. The Company’s critical accounting policies and the resultant estimates considered most significant by management are disclosed in the Annual Report. During the nine month period ended September 30, 2017, there were no changes to the critical accounting policies or related estimates from those disclosed in the Annual Report.
Overall Corporate Results
The following presents the Company’s revenue, expenses and net income for the three month and nine month periods ended September 30, 2017 and the comparable periods in 2016:
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Insurance premiums
|
$
|
42,094
|
$
|
39,432
|
$
|
122,996
|
$
|
117,012
|
||||||||
Investment income
|
2,136
|
2,453
|
6,380
|
7,523
|
||||||||||||
Realized investment gains, net
|
539
|
527
|
2,818
|
1,411
|
||||||||||||
Other income
|
29
|
35
|
95
|
102
|
||||||||||||
Total revenue
|
44,798
|
42,447
|
132,289
|
126,048
|
||||||||||||
Insurance benefits and losses incurred
|
30,417
|
26,955
|
87,446
|
78,702
|
||||||||||||
Commissions and underwriting expenses
|
10,176
|
11,558
|
31,800
|
34,339
|
||||||||||||
Other expense
|
3,134
|
3,221
|
9,301
|
9,803
|
||||||||||||
Interest expense
|
440
|
396
|
1,273
|
1,154
|
||||||||||||
Total benefits and expenses
|
44,167
|
42,130
|
129,820
|
123,998
|
||||||||||||
Income before income taxes
|
$
|
631
|
$
|
317
|
$
|
2,469
|
$
|
2,050
|
||||||||
Net income
|
$
|
747
|
$
|
149
|
$
|
1,986
|
$
|
1,288
|
Management also considers and evaluates performance by analyzing the non-GAAP measure operating income (loss), and believes it is a useful metric for investors, potential investors, securities analysts and others because it isolates the “core” operating results of the Company before considering certain items that are either beyond the control of management (such as taxes, which are subject to timing, regulatory and rate changes depending on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company’s operational results (such as any realized investment gains, which are not a part of the Company’s primary operations and are, to a limited extent, subject to discretion in terms of timing of realization).
A reconciliation of net income to operating income (loss) for the three month and nine month periods ended September 30, 2017 and the comparable periods in 2016 is as follows:
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
Reconciliation of Non-GAAP Financial Measure
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
(In thousands)
|
||||||||||||||||
Net income
|
$
|
747
|
$
|
149
|
$
|
1,986
|
$
|
1,288
|
||||||||
Income tax expense (benefit)
|
(116
|
)
|
168
|
483
|
762
|
|||||||||||
Realized investment gains, net
|
(539
|
)
|
(527
|
)
|
(2,818
|
)
|
(1,411
|
)
|
||||||||
Operating income (loss)
|
$
|
92
|
$
|
(210
|
)
|
$
|
(349
|
)
|
$
|
639
|
On a consolidated basis, the Company had net income of $0.7 million, or $0.03 per diluted share, for the three month period ended September 30, 2017, compared to net income of $0.1 million, or nil per diluted share, for the three month period ended September 30, 2016. The Company had net income of $2.0 million, or $0.08 per diluted share, for the nine month period ended September 30, 2017, compared to net income of $1.3 million, or $0.05 per diluted share, for the nine month period ended September 30, 2016. Premium revenue for the three month period ended September 30, 2017 increased $2.7 million, or 6.8%, to $42.1 million from $39.4 million in the three month period ended September 30, 2016. For the nine month period ended September 30, 2017, premium revenue increased $6.0 million, or 5.1%, to $123.0 million from $117.0 million in the comparable 2016 period. The increase in premium revenue for the three month and nine month periods ended September 30, 2017 was primarily attributable to an increase in Medicare supplement business in the life and health operations. The increase in net income for the three month and nine month periods ended September 30, 2017 was due primarily to the increase in premium revenue, as well as an increase in realized investment gains. Operating income increased $0.3 million in the three month period ended September 30, 2017 over the three month period ended September 30, 2016, and decreased $1.0 million during the nine month period ended September 30, 2017, from the comparable period in 2016. The increase in operating income for the three month period ended September 30, 2017 was primarily due to increased profitability in the property and casualty operations. Partially offsetting the increase in operating income for the three month period ended September 30, 2017 was a decrease in investment income attributable to a decrease in the average yield on the Company’s investments in fixed maturities and a loss from the equity in earnings from investments in real estate partnerships. The decrease in operating income for the nine month period ended September 30, 2017 was primarily attributable to unfavorable loss experience in the life and health operations and the decrease in investment income discussed previously.
A more detailed analysis of the individual operating companies and other corporate activities follows.
American Southern
The following summarizes American Southern’s premiums, losses, expenses and underwriting ratios for the three month and nine month periods ended September 30, 2017 and the comparable periods in 2016:
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
(Dollars in thousands)
|
||||||||||||||||
Gross written premiums
|
$
|
9,520
|
$
|
8,704
|
$
|
46,505
|
$
|
43,766
|
||||||||
Ceded premiums
|
(1,238
|
)
|
(1,184
|
)
|
(3,592
|
)
|
(3,519
|
)
|
||||||||
Net written premiums
|
$
|
8,282
|
$
|
7,520
|
$
|
42,913
|
$
|
40,247
|
||||||||
Net earned premiums
|
$
|
14,046
|
$
|
12,884
|
$
|
40,268
|
$
|
40,376
|
||||||||
Net loss and loss adjustment expenses
|
9,663
|
8,507
|
25,879
|
25,238
|
||||||||||||
Underwriting expenses
|
3,525
|
3,751
|
11,583
|
12,535
|
||||||||||||
Underwriting income
|
$
|
858
|
$
|
626
|
$
|
2,806
|
$
|
2,603
|
||||||||
Loss ratio
|
68.8
|
%
|
66.0
|
%
|
64.3
|
%
|
62.5
|
%
|
||||||||
Expense ratio
|
25.1
|
29.1
|
28.7
|
31.1
|
||||||||||||
Combined ratio
|
93.9
|
%
|
95.1
|
%
|
93.0
|
%
|
93.6
|
%
|
Gross written premiums at American Southern increased $0.8 million, or 9.4%, during the three month period ended September 30, 2017, and $2.7 million, or 6.3%, during the nine month period ended September 30, 2017, over the comparable periods in 2016. The increase in gross written premiums for the three month and nine month periods ended September 30, 2017 was primarily attributable to an increase in automobile liability written premiums from existing programs. Also contributing to the increase in gross written premiums for the nine month period ended September 30, 2017 were increases in automobile physical damage and surety business from two new agencies.
Ceded premiums increased slightly during the three month and nine month periods ended September 30, 2017 over the comparable periods in 2016 due primarily to a reinsurance rate increase in the automobile liability line of business.
The following presents American Southern’s net earned premiums by line of business for the three month and nine month periods ended September 30, 2017 and the comparable periods in 2016:
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Automobile liability
|
$
|
7,971
|
$
|
6,646
|
$
|
22,103
|
$
|
20,804
|
||||||||
Automobile physical damage
|
2,424
|
2,511
|
7,297
|
7,675
|
||||||||||||
General liability
|
745
|
747
|
2,211
|
2,274
|
||||||||||||
Surety
|
2,091
|
2,212
|
6,418
|
7,002
|
||||||||||||
Other lines
|
815
|
768
|
2,239
|
2,621
|
||||||||||||
Total
|
$
|
14,046
|
$
|
12,884
|
$
|
40,268
|
$
|
40,376
|
Net earned premiums increased $1.2 million, or 9.0%, during the three month period ended September 30, 2017 over the three month period ended September 30, 2016, and decreased $0.1 million, or 0.3%, during the nine month period ended September 30, 2017, from the comparable period in 2016. The increase in net earned premiums for the three month period ended September 30, 2017 was primarily attributable to an increase in automobile liability earned premiums due to retrospective premium adjustments for certain accounts. The decrease in net earned premiums for the nine month period ended September 30, 2017 was primarily due to decreased writings in 2016 for automobile physical damage, surety and property lines of business. Premiums are earned ratably over their respective policy terms, and therefore premiums earned in the current year are related to policies written during both the current year and immediately preceding year.
The performance of an insurance company is often measured by its combined ratio. The combined ratio represents the percentage of losses, loss adjustment expenses and other expenses that are incurred for each dollar of premium earned by the company. A combined ratio of under 100% represents an underwriting profit while a combined ratio of over 100% indicates an underwriting loss. The combined ratio is divided into two components, the loss ratio (the ratio of losses and loss adjustment expenses incurred to premiums earned) and the expense ratio (the ratio of expenses incurred to premiums earned).
Net loss and loss adjustment expenses at American Southern increased $1.2 million, or 13.6%, during the three month period ended September 30, 2017, and $0.6 million, or 2.5%, during the nine month period ended September 30, 2017, over the comparable periods in 2016. As a percentage of earned premiums, net loss and loss adjustment expenses were 68.8% in the three month period ended September 30, 2017, compared to 66.0% in the three month period ended September 30, 2016. For the nine month period ended September 30, 2017, this ratio increased to 64.3% from 62.5% in the comparable period of 2016. The increase in the loss ratio for the three month period ended September 30, 2017 was primarily due to an increase in automobile liability claims from one of the company’s governmental programs. The increase in the loss ratio for the nine month period ended September 30, 2017 was primarily attributable to less favorable loss experience in the general liability and surety lines of business, as well as a $0.5 million loss recovery in the 2016 year to date period that did not recur in the comparable period of 2017.
Underwriting expenses decreased $0.2 million, or 6.0%, during the three month period ended September 30, 2017 and $1.0 million, or 7.6%, during the nine month period ended September 30, 2017, from the comparable periods in 2016. As a percentage of earned premiums, underwriting expenses were 25.1% in the three month period ended September 30, 2017, compared to 29.1% in the three month period ended September 30, 2016. For the nine month period ended September 30, 2017, this ratio decreased to 28.7% from 31.1% in the comparable period of 2016. The change in the expense ratio for the three month and nine month periods ended September 30, 2017 was primarily due to American Southern’s use of a variable commission structure with certain agents, which compensates the participating agents in relation to the loss ratios of the business they write. As a result of this structure, during periods in which the loss ratio increases, commissions and underwriting expenses will generally decrease, and conversely, during periods in which the loss ratio decreases, commissions and underwriting expenses will generally increase. During the three month and nine month periods ended September 30, 2017, variable commissions at American Southern decreased $0.2 million and $0.5 million, respectively, from the comparable periods of 2016 due to less favorable loss experience from accounts subject to variable commissions.
Bankers Fidelity
The following summarizes Bankers Fidelity’s earned premiums, losses, expenses and underwriting ratios for the three month and nine month periods ended September 30, 2017 and the comparable periods in 2016:
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
2017
|
2016
|
2017
|
2016
|
|||||||||||||
(Dollars in thousands)
|
||||||||||||||||
Medicare supplement
|
$
|
24,002
|
$
|
22,571
|
$
|
70,647
|
$
|
64,801
|
||||||||
Other health products
|
1,641
|
1,405
|
4,749
|
4,189
|
||||||||||||
Life insurance
|
2,405
|
2,572
|
7,332
|
7,646
|
||||||||||||
Total earned premiums
|
28,048
|
26,548
|
82,728
|
76,636
|
||||||||||||
Insurance benefits and losses
|
20,754
|
18,448
|
61,567
|
53,464
|
||||||||||||
Underwriting expenses
|
8,505
|
9,612
|
26,000
|
27,371
|
||||||||||||
Total expenses
|
29,259
|
28,060
|
87,567
|
80,835
|
||||||||||||
Underwriting loss
|
$
|
(1,211
|
)
|
$
|
(1,512
|
)
|
$
|
(4,839
|
)
|
$
|
(4,199
|
)
|
||||
Loss ratio
|
74.0
|
%
|
69.5
|
%
|
74.4
|
%
|
69.8
|
%
|
||||||||
Expense ratio
|
30.3
|
36.2
|
31.4
|
35.7
|
||||||||||||
Combined ratio
|
104.3
|
%
|
105.7
|
%
|
105.8
|
%
|
105.5
|
%
|
Premium revenue at Bankers Fidelity increased $1.5 million, or 5.7%, during the three month period ended September 30, 2017, and $6.1 million, or 7.9%, during the nine month period ended September 30, 2017, over the comparable periods in 2016. Premiums from the Medicare supplement line of business increased $1.4 million, or 6.3%, during the three month period ended September 30, 2017, and $5.8 million, or 9.0%, during the nine month period ended September 30, 2017, due primarily to the successful execution of new business generating strategies with both new and existing agents. Other health product premiums increased $0.2 million and $0.6 million, respectively, during the same comparable periods, primarily as a result of new sales of the company’s disability income and group health products. Premiums from the life insurance line of business decreased $0.2 million, or 6.5%, during the three month period ended September 30, 2017, and $0.3 million, or 4.1%, during the nine month period ended September 30, 2017 from the comparable 2016 periods due to the redemption and settlement of existing policy obligations exceeding the level of new sales activity. During the fourth quarter of 2016, Bankers Fidelity entered into a reinsurance agreement to moderate statutory capital requirements related to premium growth in the Medicare supplement line of business. Medicare supplement premiums ceded under the reinsurance agreement in the three month and nine month periods ended September 30, 2017 were approximately $8.6 million and $19.7 million, respectively.
Benefits and losses increased $2.3 million, or 12.5%, during the three month period ended September 30, 2017, and $8.1 million, or 15.2%, during the nine month period ended September 30, 2017, over the comparable periods in 2016. As a percentage of earned premiums, benefits and losses were 74.0% in the three month period ended September 30, 2017, compared to 69.5% in the three month period ended September 30, 2016. For the nine month period ended September 30, 2017, this ratio increased to 74.4% from 69.8% in the comparable period of 2016. The increase in the loss ratio for the three month and nine month periods ended September 30, 2017 was primarily attributable to unfavorable loss experience in the Medicare supplement line. Further, beginning late in 2016 and continuing throughout the first quarter of 2017, Bankers Fidelity experienced significantly increased levels of mortality and morbidity across all lines of business which had an unfavorable effect on the company’s loss patterns and increased the resultant 2017 year to date loss ratio.
Underwriting expenses decreased $1.1 million, or 11.5%, during the three month period ended September 30, 2017, and $1.4 million, or 5.0%, during the nine month period ended September 30, 2017, from the comparable periods in 2016. As a percentage of earned premiums, underwriting expenses were 30.3% in the three month period ended September 30, 2017, compared to 36.2% in the three month period ended September 30, 2016. For the nine month period ended September 30, 2017, this ratio decreased to 31.4% from 35.7% in the comparable period of 2016. The decrease in the expense ratio for the three month and nine month periods ended September 30, 2017 was primarily due to the increase in earned premiums coupled with a relatively consistent level of fixed general and administrative expenses. Also contributing to the decrease in the expense ratio was a reinsurance expense-reimbursement allowance associated with the reinsurance agreement described above, which reimbursed the company for a portion of its indirect underwriting expenses.
INVESTMENT INCOME AND REALIZED GAINS
Investment income decreased $0.3 million, or 12.9%, during the three month period ended September 30, 2017, and $1.1 million, or 15.2%, during the nine month period ended September 30, 2017, from the comparable periods in 2016. The decrease in investment income for the three month and nine month periods ended September 30, 2017 was attributable to a decrease in the average yield on the Company’s investments in fixed maturities and losses for the 2017 quarter and year to date period of $0.1 million and $0.5 million, respectively, from the equity in earnings from investments in real estate partnerships.
The Company had net realized investment gains of $0.5 million during each of the three month periods ended September 30, 2017 and September 30, 2016. The Company had net realized investment gains of $2.8 million during the nine month period ended September 30, 2017, compared to net realized investment gains of $1.4 million in the nine month period ended September 30, 2016. The net realized investment gains in the three month and nine month periods ended September 30, 2017 were primarily attributable to gains from the sale of an equity security and a number of the Company’s investments in fixed maturities. The net realized investment gains in the three month and nine month periods ended September 30, 2016 resulted primarily from the disposition of several of the Company’s investments in fixed maturities. Net realized investment gains in the nine month period ended September 30, 2016 also included a $0.6 million gain from the sale of property held within one of the Company’s real estate partnership investments. Management continually evaluates the Company’s investment portfolio and, as may be determined to be appropriate, makes adjustments for impairments and/or will divest investments.
INTEREST EXPENSE
Interest expense increased slightly during the three month period ended September 30, 2017, and $0.1 million, or 10.3%, during the nine month period ended September 30, 2017, over the comparable periods in 2016. The increase in interest expense for the three month and nine month periods ended September 30, 2017 was due to an increase in the London Interbank Offered Rate (“LIBOR”), as the interest rates on the Company’s outstanding junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) are directly related to LIBOR.
OTHER EXPENSES
Other expenses (commissions, underwriting expenses, and other expenses) decreased $1.5 million, or 9.9%, during the three month period ended September 30, 2017, and $3.0 million, or 6.9%, during the nine month period ended September 30, 2017, from the comparable periods in 2016. The decrease in other expenses for the three month and nine month periods ended September 30, 2017 was primarily attributable to a reinsurance expense-reimbursement allowance associated with the reinsurance agreement in the life and health operations, which reimbursed a portion of the Company’s indirect underwriting expenses. Also contributing to the decrease for the three month and nine month periods ended September 30, 2017 were decreases of $0.2 million and $0.5 million, respectively, in the variable commission accrual in the property and casualty operations. On a consolidated basis, as a percentage of earned premiums, other expenses decreased to 31.6% in the three month period ended September 30, 2017 from 37.5% in the three month period ended September 30, 2016. For the nine month period ended September 30, 2017, this ratio decreased to 33.4% from 37.7% in the comparable period of 2016. The decrease in the expense ratio for the three month and nine month periods ended September 30, 2017 was primarily attributable to the increase in earned premiums coupled with a lower level of general and administrative expenses.
INCOME TAXES
The primary differences between the effective tax rate and the federal statutory income tax rate for the three month and nine month periods ended September 30, 2017 resulted from the dividends-received deduction (“DRD”) and the small life insurance company deduction (“SLD”). The current estimated DRD is adjusted as underlying factors change and can vary from estimates based on, but not limited to, actual distributions from investments as well as the amount of the Company’s taxable income. The SLD varies in amount and is determined at a rate of 60 percent of the tentative life insurance company taxable income (“LICTI”). The SLD for any taxable year is reduced (but not below zero) by 15 percent of the tentative LICTI for such taxable year as it exceeds $3.0 million and is ultimately phased out at $15.0 million.
The primary differences between the effective tax rate and the federal statutory income tax rate for the three month and nine month periods ended September 30, 2016 resulted from the provision-to-filed return adjustments, described below, and the DRD.
The provision-to-filed return adjustments are generally updated at the completion of the third quarter of each fiscal year, after the Company’s tax return for the previous year is filed with the IRS. See Note 8 of Notes to Condensed Consolidated Financial Statements.
LIQUIDITY AND CAPITAL RESOURCES
The primary cash needs of the Company are for the payment of claims and operating expenses, maintaining adequate statutory capital and surplus levels, and meeting debt service requirements. Current and expected patterns of claim frequency and severity may change from period to period but generally are expected to continue within historical ranges. The Company’s primary sources of cash are written premiums, investment income and proceeds from the sale and maturity of its invested assets. The Company believes that, within each operating company, total invested assets will be sufficient to satisfy all policy liabilities and that cash inflows from investment earnings, future premium receipts and reinsurance collections will be adequate to fund the payment of claims and expenses as needed.
Cash flows at the Parent are derived from dividends, management fees, and tax-sharing payments, as described below, from the subsidiaries. The principal cash needs of the Parent are for the payment of operating expenses, the acquisition of capital assets and debt service requirements, as well as the repurchase of shares and payments of any dividends as may be authorized and approved by the Company’s board of directors from time to time. At September 30, 2017, the Parent had approximately $22.0 million of unrestricted cash and investments.
The Parent’s insurance subsidiaries reported statutory net income of $2.0 million for the nine month period ended September 30, 2017 compared to statutory net income of $4.6 million for the nine month period ended September 30, 2016. Statutory results are impacted by the recognition of all costs of acquiring business. In periods in which the Company’s first year premiums increase, statutory results are generally lower than results determined under GAAP. Statutory results for the Company’s property and casualty operations may differ from the Company’s results of operations under GAAP due to the deferral of acquisition costs for financial reporting purposes. The Company’s life and health operations’ statutory results may differ from GAAP results primarily due to the deferral of acquisition costs for financial reporting purposes, as well as the use of different reserving methods.
Over 90% of the invested assets of the Parent’s insurance subsidiaries are invested in marketable securities that can be converted into cash, if required; however, the use of such assets by the Company is limited by state insurance regulations. Dividend payments to a parent corporation by its wholly owned insurance subsidiaries are subject to annual limitations and are restricted to 10% of statutory surplus or statutory earnings before recognizing realized investment gains of the individual insurance subsidiaries. At September 30, 2017 American Southern had $43.0 million of statutory surplus and Bankers Fidelity had $29.7 million of statutory surplus. In 2017, dividend payments by the Parent’s insurance subsidiaries in excess of $5.7 million would require prior approval. During the nine month period September 30, 2017, the Parent received dividends of $3.6 million from its subsidiaries.
The Parent provides certain administrative and other services to each of its insurance subsidiaries. The amounts charged to and paid by the subsidiaries include reimbursements for various shared services and other expenses incurred directly on behalf of the subsidiaries by the Parent. In addition, there is in place a formal tax-sharing agreement between the Parent and its insurance subsidiaries. As a result of the Parent’s tax loss, it is anticipated that the tax-sharing agreement will continue to provide the Parent with additional funds from profitable subsidiaries to assist in meeting its cash flow obligations.
The Company has two statutory trusts which exist for the exclusive purpose of issuing trust preferred securities representing undivided beneficial interests in the assets of the trusts and investing the gross proceeds of the trust preferred securities in Junior Subordinated Debentures. The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable quarterly, in whole or in part, only at the option of the Company, and have an interest rate of three-month LIBOR plus an applicable margin. The margin ranges from 4.00% to 4.10%. At September 30, 2017, the effective interest rate was 5.37%. The obligations of the Company with respect to the issuances of the trust preferred securities represent a full and unconditional guarantee by the Parent of each trust’s obligations with respect to the trust preferred securities. Subject to certain exceptions and limitations, the Company may elect from time to time to defer Junior Subordinated Debenture interest payments, which would result in a deferral of distribution payments on the related trust preferred securities. The Company has not made such an election.
The Company intends to pay its obligations under the Junior Subordinated Debentures using existing cash balances, dividend and tax-sharing payments from the operating subsidiaries, or from potential future financing arrangements.
At September 30, 2017, the Company had 55,000 shares of Series D preferred stock (“Series D Preferred Stock”) outstanding. All of the shares of Series D Preferred Stock are held by an affiliate of the Company’s controlling shareholder. The outstanding shares of Series D Preferred Stock have a stated value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company’s common stock at the option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company’s common stock, subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company’s option. The Series D Preferred Stock is not currently convertible. At September 30, 2017, the Company had accrued but unpaid dividends on the Series D Preferred Stock totaling $0.3 million.
Cash and cash equivalents decreased from $13.3 million at December 31, 2016 to $9.5 million at September 30, 2017. The decrease in cash and cash equivalents during the nine month period ended September 30, 2017 was primarily attributable to net cash used in operating activities of $1.1 million, investment purchases exceeding the sale and maturity of securities by $1.6 million, additions to property and equipment of $0.1 million, dividends paid on the Company’s common stock of $0.4 million and the purchase of shares for treasury for $0.5 million.
The Company believes that existing cash balances as well as the dividends, fees, and tax-sharing payments it expects to receive from its subsidiaries and, if needed, additional borrowings from financial institutions, will enable the Company to meet its liquidity requirements for the foreseeable future. Management is not aware of any current recommendations by regulatory authorities, which, if implemented, would have a material adverse effect on the Company’s liquidity, capital resources or operations.
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Securities Exchange Act of 1934 (the “Exchange Act”) reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management necessarily applies its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding management’s control objectives. The Company’s management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures can prevent all possible errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. There are inherent limitations in all control systems, including the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the intentional acts of one or more persons. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and, while our disclosure controls and procedures are designed to be effective under circumstances where they should reasonably be expected to operate effectively, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of the inherent limitations in any control system, misstatements due to possible errors or fraud may occur and may not be detected. An evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
There have been no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains and references certain information that constitutes forward-looking statements as that term is defined in the federal securities laws. Those statements, to the extent they are not historical facts, should be considered forward-looking statements, and are subject to various risks and uncertainties. Such forward-looking statements are made based upon management’s current assessments of various risks and uncertainties, as well as assumptions made in accordance with the “safe harbor” provisions of the federal securities laws. The Company’s actual results could differ materially from the results anticipated in these forward-looking statements as a result of such risks and uncertainties, including those identified in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and subsequent Quarterly Reports on Form 10-Q, and other filings made by the Company from time to time with the Securities and Exchange Commission. In addition, other risks and uncertainties not known by us, or that we currently determine to not be material, may materially adversely affect our financial condition, results of operations or cash flows. The Company undertakes no obligation to update any forward-looking statement as a result of subsequent developments, changes in underlying assumptions or facts, or otherwise.
PART II. OTHER INFORMATION
On October 31, 2016, the Board of Directors of the Company approved a plan that allows for the repurchase of up to 750,000 shares of the Company’s common stock (the “Repurchase Plan”) on the open market or in privately negotiated transactions, as determined by an authorized officer of the Company. Any such repurchases can be made from time to time in accordance with applicable securities laws and other requirements.
Other than pursuant to the Repurchase Plan, no purchases of common stock of the Company were made by or on behalf of the Company during the periods described below.
The table below sets forth information regarding repurchases by the Company of shares of its common stock on a monthly basis during the three month period ended September 30, 2017.
Period
|
Total Number
of Shares
Purchased
|
Average
Price Paid
per Share
|
Total Number of
Shares Purchased
as Part of
Publicly
Announced Plans
or Programs
|
Maximum
Number of
Shares that
May Yet be
Purchased
Under the
Plans or
Programs
|
||||||||||||
July 1 – July 31, 2017
|
83,978
|
$
|
3.65
|
83,978
|
599,606
|
|||||||||||
August 1 – August 31, 2017
|
4,226
|
3.51
|
4,226
|
595,380
|
||||||||||||
September 1 – September 30, 2017
|
9,893
|
3.36
|
9,893
|
585,487
|
||||||||||||
Total
|
98,097
|
$
|
3.62
|
98,097
|
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
101.INS
|
XBRL Instance Document.
|
101.SCH
|
XBRL Taxonomy Extension Schema.
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase.
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase.
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase.
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase.
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ATLANTIC AMERICAN CORPORATION
(Registrant)
Date: November 14, 2017
|
By:
|
/s/ J. Ross Franklin
|
|
J. Ross Franklin
|
|||
Interim Chief Financial Officer
|
|||
(Principal Financial and Accounting Officer)
|
-31-